Conflict of Interest and Quality Assurance
The information presented at the 5th World Congress of the International Academy of Oral Oncology (IAOO) and the sponsored CME Activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the Congress will provide information that speakers have disclosed about financial relationships they have with commercial entities which produce or market products or services related to the content of CME Activities. The disclosure information will be made available in the Abstract Book of the 5th World Congress of the IAOO, distributed on site to delegates. In addition, the presence of such a relationship will be reported to the program attendees at the presentation. Presenters and faculty members shall also disclose their intent to discuss drugs or devices or the uses of drugs or devices that have not been approved by the Food and Drug Administration (FDA) of USA and the equivalent authority of the European Union (EU). Reasonable efforts will be taken to ensure that educational subject matters are presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions.
The 5th World Congress of the IAOO is committed to the non promotional advancement of knowledge and science in the research and treatment of oral cancer.